Tag: AstraZeneca

FARXIGA meets primary endpoint in Phase III DAPA-HF trial

AstraZeneca has announced positive results from the Phase III DAPA-HF trial which showed that FA...

Orodispersible tablets of ticagrelor now available in the UK

AstraZeneca has announced the UK availability of ticagrelor (Brilique) 90mg orodispersible tablets. ...

NICE recommends dual antiplatelet therapy with ticagrelor and aspirin

The National Institute of Health and Care Excellence (NICE) has published a final appraisal determin...